Exelixis
EXEL
#1323
Rank
โ‚ฌ15.16 B
Marketcap
62,13ย โ‚ฌ
Share price
1.25%
Change (1 day)
73.40%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

EPS for Exelixis (EXEL)

EPS in 2023 (TTM): 0,26ย โ‚ฌ

According to Exelixis's latest financial reports the company's current EPS (TTM) is 3,09ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 0,51ย โ‚ฌ a decrease over its 2021 EPS that were of 0,66ย โ‚ฌ.

EPS history for Exelixis from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)0,26ย โ‚ฌ-49.18%
20220,51ย โ‚ฌ-22.97%
20210,66ย โ‚ฌ100%
20200,33ย โ‚ฌ-65.09%
20190,95ย โ‚ฌ-53.91%
20182,05ย โ‚ฌ333.96%
20170,47ย โ‚ฌ-260.61%
2016-0,29ย โ‚ฌ-58.75%
2015-0,71ย โ‚ฌ-42.45%
2014-1,24ย โ‚ฌ5.3%
2013-1,18ย โ‚ฌ43.48%
2012-0,82ย โ‚ฌ-264.29%
20110,50ย โ‚ฌ-165.88%
2010-0,76ย โ‚ฌ-32.54%
2009-1,13ย โ‚ฌ-17.65%
2008-1,37ย โ‚ฌ75.86%
2007-0,78ย โ‚ฌ-25.64%
2006-1,04ย โ‚ฌ8.33%
2005-0,96ย โ‚ฌ-42.86%
2004-1,69ย โ‚ฌ30.34%
2003-1,29ย โ‚ฌ-5.23%
2002-1,37ย โ‚ฌ-0.65%
2001-1,38ย โ‚ฌ-51.88%
2000-2,86ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
5,97ย โ‚ฌ 93.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
0,68ย โ‚ฌ-78.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
14,49ย โ‚ฌ 368.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1,70ย โ‚ฌ-45.00%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
0,89ย โ‚ฌ-71.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,04ย โ‚ฌ 30.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,57ย โ‚ฌ-16.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-12,70ย โ‚ฌ-510.98%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-0,75ย โ‚ฌ-124.28%๐Ÿ‡บ๐Ÿ‡ธ USA